Antiepileptic drugs in the 21st century

CNS Spectrums

Volumn 6, Issue 9, 2001, Pages 756-765

  Bazil, C W ^a  

^a Columbia Compreh Epilepsy Ctr ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; ZOVEGRAM;

ABSENCE; DOSE CALCULATION; DRUG CHOICE; DRUG HALF LIFE; DRUG INDICATION; EPILEPSY; GENERALIZED EPILEPSY; HUMAN; INFANTILE SPASM; PRIORITY JOURNAL; REVIEW; TITRIMETRY;

EID: 0034754276     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900001504     Document Type: Review

References (54)

1. Phenytoin: Mechanisms of action
2. Progress report on new antieplleptic drugs: A summary, of the fourth Eilat conference (EILAT IV)
3. Antiepileptic drugs
4. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
5. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
6. Carbamazepine
7. Intravenous loading of valproate for epilepsy
8. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients
9. Valproic acid hepatic fatalities: A retrospective review
10. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy
11. Valproate
12. Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons
13. New options for the treatment of epilepsy
14. Gabapentin bioavailability: Effect of dose and frequency of administration in adult patients with epilepsy
15. Pharmacological studies on lamotrigine, a novel potential antieplleptic drug. II. Neurochemieal studies on the mechanism of action
16. Lamotrigine
17. New antiepileptic drugs
18. Lamotrigine-induced severe cutaneous adverse reactions
19. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs
20. Safety of topiramate: Adverse events and relationships to dosing
21. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment
22. Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
23. Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on named-patient basis
24. Blockade of sustained repetitive action potentials in cultures of spinal cord neurons by zonisamide (AD 810, C1912), a novel anticonvulsant
25. Advances in the medical treatment of epilepsy
26. Effects of zonisamide on dopaminergic systems
27. Efficacy and safety of zonisamide: Results of a multicenter study
28. A comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonie-clonic seizures
29. Comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults
30. The new antiepileptic drugs: A systematic review of their efficacy and tolerability
31. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
32. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
33. Comparison of oxcarbazepine and carbamazepine: A double-blind study
34. A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
35. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: A randomized, double-blind, dose titration study
36. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
37. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin
38. Antiepileptie drugs as a cause of worsening seizures
39. Congenital malformations
40. Teratogenicity of anticonvulsant drugs I: Review of the literature
41. Teratogenicity of antiepileptic drugs
42. The new antiepileptic drugs and women: Efficacy, reproductive health, pregnancy, and fetal outcome
43. The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients
44. The evolving role of antiepileptic drugs in treating neuropathic pain
45. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus
46. Gabapentin for the treatment of postherpeutic neuralgia
47. Treatment of social phobia with gabapentin: A placebo-controlled study
48. Placebo-controlled study of gabapentin treatment of panic disorder
49. Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy
50. Lamotrigine for central poststroke pain
51. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy
52. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
53. Topiramate relieves refractory, trigeminal neuralgia in MS patients
54. Effects of anticonvulsants on nocturnal sleep in epilepsy